Evidence map›Paper›PMID 37443647›Full record

ReviewDiagnostics (Basel, Switzerland)2023

Unravelling Peritoneal Carcinomatosis Using Cross-Sectional Imaging Modalities.

Ana Veron Sanchez, Ilias Bennouna, Nicolas Coquelet, Jorge Cabo Bolado, Inmaculada Pinilla Fernandez, Luis A Mullor Delgado, Martina Pezzullo, Gabriel Liberale, Maria Gomez Galdon, Maria A Bali

Open access · goldAbstract readReview
In one paragraph

Review in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. The Many Faces of the Angry Peritoneum.Diagnostics (Basel, Switzerland) · 2025
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Ana Veron SanchezHospital Universitaire de Bruxelles, Institut Jules Bordet, 1070 Brussels, Belgium.ORCID 0000-0002-8098-4577
Ilias BennounaHospital Universitaire de Bruxelles, Institut Jules Bordet, 1070 Brussels, Belgium.
Nicolas CoqueletHospital Universitaire de Bruxelles, Institut Jules Bordet, 1070 Brussels, Belgium.
Jorge Cabo BoladoTeleconsult, Milton Keynes MK12 5NE, UK.
Inmaculada Pinilla FernandezHospital Universitario La Paz, 28046 Madrid, Spain.
Luis A Mullor DelgadoHospital Universitario Gregorio Marañon, 28009 Madrid, Spain.
Martina PezzulloHôpital Universitaire de Bruxelles, Hôpital Erasme, 1070 Brussels, Belgium.
Gabriel LiberaleHospital Universitaire de Bruxelles, Institut Jules Bordet, 1070 Brussels, Belgium.
Maria Gomez GaldonHospital Universitaire de Bruxelles, Institut Jules Bordet, 1070 Brussels, Belgium.
Maria A BaliHospital Universitaire de Bruxelles, Institut Jules Bordet, 1070 Brussels, Belgium.
Institut Jules Bordet · BEErasmus Hospital · BEHospital General Universitario Gregorio Marañón · ESHospital Universitario La Paz · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peritoneal carcinomatosis (PC) refers to malignant epithelial cells that spread to the peritoneum, principally from abdominal malignancies. Until recently, PC prognosis has been considered ill-fated, with palliative therapies serving as the only treatment option. New locoregional treatments are changing the outcome of PC, and imaging modalities have a critical role in early diagnosis and disease staging, determining treatment decision making strategies. The aim of this review is to provide a practical approach for detecting and characterizing peritoneal deposits in cross-sectional imaging modalities, taking into account their appearances, including the secondary complications, the anatomical characteristics of the peritoneal cavity, together with the differential diagnosis with other benign and malignant peritoneal conditions. Among the cross-sectional imaging modalities, computed tomography (CT) is widely available and fast; however, magnetic resonance (MR) performs better in terms of sensitivity (92% vs. 68%), due to its higher contrast resolution. The appearance of peritoneal deposits on CT and MR mainly depends on the primary tumour histology; in case of unknown primary tumour (3-5% of cases), their behaviour at imaging may provide insights into the tumour origin. The timepoint of tumour evolution, previous or ongoing treatments, and the peritoneal spaces in which they occur also play an important role in determining the appearance of peritoneal deposits. Thus, knowledge of peritoneal anatomy and fluid circulation is essential in the detection and characterisation of peritoneal deposits. Several benign and malignant conditions show similar imaging features that overlap those of PC, making differential diagnosis challenging. Knowledge of peritoneal anatomy and primary tumour histology is crucial, but one must also consider clinical history, laboratory findings, and previous imaging examinations to achieve a correct diagnosis. In conclusion, to correctly diagnose PC in cross-sectional imaging modalities, knowledge of peritoneal anatomy and peritoneal fluid flow characteristics are mandatory. Peritoneal deposit features reflect the primary tumour characteristics, and this specificity may be helpful in its identification when it is unknown. Moreover, several benign and malignant peritoneal conditions may mimic PC, which need to be considered even in oncologic patients.

Indexed as

carcinomatosisdepositsperitoneum

Identifiers

PMID37443647
PMCPMC10340753
OpenAlexW4382987074

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.